NEW YORK (GenomeWeb News) – Strategic Diagnostics and the Fred Hutchinson Cancer Center said yesterday that they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.

Under the collaboration, which will initially focus on pancreatic cancer, Newark, NJ-based SDI will provide approximately 1,000 of its cancer antigen antibodies to Paul Lampe, full member and associate program head of the Molecular Diagnostics Program at Seattle's Hutchinson Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.